Sign In
Buy GILD
$125.05
+0.180 (+0.144%)
At Close: Jun 23, 2026
Despite Expected Low Earnings Growth, GILD Is Bullish Into Next Year
07:22pm, Wednesday, 22'nd Jun 2022 Investing.com
Why Eli Lilly's Immunology Prospects Look Promising
12:30pm, Monday, 20'th Jun 2022 The Motley Fool
Uplifting news turns the tide in immunology.
Seven reasons the beleaguered biotech sector is now a 'buy'
11:33am, Saturday, 18'th Jun 2022 MarketWatch
Investors ought to take advantage of low prices for a long-term view.
1 of the Safest Dividend Stocks on Earth
10:39am, Friday, 17'th Jun 2022 The Motley Fool
This beaten-down biotech is paying a 5.1% dividend -- three times the average dividend on the S&P 500.
1 of the Safest Dividend Stocks on Earth
06:39am, Friday, 17'th Jun 2022
This beaten-down biotech is paying a 5.1% dividend -- three times the average dividend on the S&P 500.
14 June High-Yield And High-Rising Dividend Dogs Ready To Buy
11:09pm, Thursday, 16'th Jun 2022
June 2022, The AAII Journal listed two sets of stocks sorted as: High-Yielding Dividend Payers, and Biggest Rising Dividend Payers. Those two articles revealed 40 dividend-paying-equities. The America
Gilead Sciences (GILD) Stock Moves -1.15%: What You Should Know
09:45pm, Thursday, 16'th Jun 2022 Zacks Investment Research
In the latest trading session, Gilead Sciences (GILD) closed at $57.72, marking a -1.15% move from the previous day.
Pfizer (PFE) COVID Pill Ineffective in Standard Risk Patients
07:22pm, Wednesday, 15'th Jun 2022 Zacks Investment Research
Pfizer (PFE) stops enrolling patients in a phase II/III study evaluating its COVID pill in standard-risk population after new data from this study showed that it is not all statistically significant.
Gilead Sciences, Inc. (GILD) CEO Dan O'Day Presents at Goldman Sachs Global Healthcare Conference (Transcript)
03:24pm, Wednesday, 15'th Jun 2022
Gilead Sciences, Inc. (NASDAQ:GILD ) Goldman Sachs Global Healthcare Conference June 15, 2022 2:20 PM ET Company Participants Dan O'Day - Chairman & Chief Executive Officer Merdad Parsey - Chief Medic
Takeda Pharmaceutical Vs. Gilead Sciences: Who Is The Dividend King?
12:02pm, Wednesday, 15'th Jun 2022
Takeda's total debt was $35,698.6 million, down 22.1% from the previous year. Takeda Pharmaceutical has a dividend yield of 5.15%, and Gilead Sciences has a dividend yield of 4.53%.
Gilead Sciences Shares Cross 5% Yield Mark
03:37pm, Tuesday, 14'th Jun 2022
In trading on Tuesday, shares of Gilead Sciences were yielding above the 5% mark based on its quarterly dividend (annualized to $2.92), with the stock changing hands as low as $57.16 on the day.
Gilead Sciences (GILD) Stock Moves -0.72%: What You Should Know
09:45pm, Friday, 10'th Jun 2022 Zacks Investment Research
Gilead Sciences (GILD) closed the most recent trading day at $60.74, moving -0.72% from the previous trading session.
ASCO 2022: Surprising News in Cancer Research
09:00pm, Friday, 10'th Jun 2022 The Motley Fool
The American Society of Clinical Oncology (ASCO) just finished up its annual meeting. We have some winners coming out of the conference.
Gilead: Lock In This High Yield
08:10am, Friday, 10'th Jun 2022
GILD trades at a significant discount to its peers on an EV/EBITDA basis. The company is seeing strong growth from its HIV and oncology platforms.
7 Surprising Stocks With Fat Dividends That Offer Some Solid Inflation Protection
07:35am, Friday, 10'th Jun 2022
We got what we expected Friday, as the consumer price index came in again at levels not seen in 40 years.
